BrainStorm Cell Therapeutics
BCLI
$0.52
Share price
0.79%
Change (1 day)
-81.16%
Change (1 year)
Categories
Earnings for BrainStorm Cell Therapeutics (BCLI)
Earnings in 2023 (TTM): -$16.64 M
According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings (TTM) are -$16.64 M. In 2022 the company made an earning of -$24.28 M an increase over its 2021 earnings that were of -$24.46 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for BrainStorm Cell Therapeutics from 2003 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$16.64 M | -31.49% |
| 2022 | -$24.28 M | -0.74% |
| 2021 | -$24.46 M | -23.12% |
| 2020 | -$31.82 M | 36.8% |
| 2019 | -$23.26 M | 66.71% |
| 2018 | -$13.95 M | 181.66% |
| 2017 | -$4.96 M | -0.6% |
| 2016 | -$4.99 M | -41.31% |
| 2015 | -$8.49 M | -8.22% |
| 2014 | -$9.25 M | 89.74% |
| 2013 | -$4.88 M | 42.27% |
| 2012 | -$3.43 M | -12.45% |
| 2011 | -$3.92 M | 63.04% |
| 2010 | -$2.4 M | 35.52% |
| 2009 | -$1.78 M | -48.99% |
| 2008 | -$3.48 M | -44.39% |
| 2007 | -$6.25 M | |
| 2005 | -$3.24 M | -91.44% |
| 2004 | -$37.78 M | 94007.62% |
| 2003 | -$0.05 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Biogen BIIB | $1.32 B | -8,056.35% | 🇺🇸 USA |
 Gilead Sciences GILD | $6.85 B | -41,339.78% | 🇺🇸 USA |
 Seagen
SGEN | -$0.8 B | 4,653.34% | 🇺🇸 USA |
 Cytokinetics
CYTK | -$0.53 B | 3,064.05% | 🇺🇸 USA |
 Agenus
AGEN | -$0.16 B | 859.07% | 🇺🇸 USA |
 Acceleron Pharma XLRN | -$0.26 B | 1,436.13% | 🇺🇸 USA |